Rigel Pharmaceuticals Inc — balance (NASDAQ:RIGL) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Activos totales 110.38 M167.33 M134.28 M117.22 M163.98 M513.59 M Total de pasivos 76.35 M136.95 M147.9 M145.87 M160.69 M122.11 M Capital total 34.03 M30.37 M-13.62 M-28.64 M3.29 M391.48 M Total de pasivos y patrimonio neto 110.38 M167.33 M134.28 M117.22 M163.98 M513.59 M Deuda total 19.82 M19.91 M39.45 M59.6 M59.68 M52.29 M Deuda neta -37.51 M-105.05 M-18.76 M2.67 M-17.64 M-102.72 M

Noticias

Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Micron and Coinbase among market cap stock movers on Wednesday

Rigel Pharmaceuticals, Inc. (RIGL) Q4 2025 Earnings Call Transcript

Diapositivas del cuarto trimestre 2025 de Rigel: crecimiento anual del 60%

Rigel T4 2025: crecimiento anual de 60%, datos prometedores en SMD

Rigel Q4 2025 slides: 60% annual growth, promising MDS data

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

X4 Pharmaceuticals: An Undercovered Biotech Trade With A Funded Path To FDA Approval

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline